| API Products in R&D | THERAPEUTIC CATEGORY | STATUS |
|---|---|---|
| Darolutamide | Oncology | Developed |
| Everolimus | Oncology | Developed |
| Elacestrant | Oncology | R&D |
| Exemestane | Oncology | R&D |
| Osimertinib | Oncology | Pilot |
| Resmetirom | NASH | Pilot |
| Rimegepant | Migraine Headache | Pilot |
| Tirzepatide | Type ll diabetic | R&D |
| Orforglipron |
Type ll diabetic & weight loss |
Phase III |
| Vosortide | Achondroplasia | R&D |
| Inclisiran | Hyperlipidemia(siRNA) | Pilot |
| Risdiplam | SMA | developed |
| Vutrisiran | ATTR(siRNA) | R&D |
| Filgotinib | Rheumatoid arthritis(JAK1) | Developed |
| Upadacitinib | Rheumatoid arthritis(JAK1) | Pilot |
| Estetrol | Estrogen | R&D |
|
Zuranolone |
MDD&PPD |
R&D |
※ Disclaimer:
Products protected by valid patents in this list are for laboratory analytical/research purposes only and are not offered for sale in countries or area wherethe sale of such products constitutes a patent infringement.Any liability is at buyer's risk.
Follow Aoruite WeChat official account